The role of regulatory T cells in the pathogenesis of sepsis and its clinical implication

Journal of Interferon and Cytokine Research

Volumn 32, Issue 8, 2012, Pages 341-349

  Jiang, Li Na ^a,b   Yao, Yong Ming ^a   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b HEBEI NORTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

BURN; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CLONAL ANERGY; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MORTALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPSIS; TH3 CELL;

ANIMALS; CLONAL ANERGY; HUMANS; IMMUNOTHERAPY; SEPSIS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84865362078     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0080     Document Type: Review

References (76)

1. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK. 2007. Activationinduced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19:345-354. (Pubitemid 46523383)
2. Baecher-Allan C, Anderson DE. 2006. Regulatory cells and human cancer. Semin Cancer Biol 16:98-105. (Pubitemid 43172058)
3. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. 2001. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167:1245-1253. (Pubitemid 32703119)
4. Banham AH. 2006. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+ regulatory T cells. Trends Immunol 27:541-544. (Pubitemid 44780852)
5. Bluestone JA, Abbas AK. 2003. Natural versus adaptive regulatory T cells. Nat Rev Immunol 3:253-257. (Pubitemid 37323210)
6. Celis R, Torres A, Gatell JM, Almela M, Rodriquez-Roisin R, Agusti-Vidal A. 1998. Nosocomial pneumonia: A multivariate analysis of risk and prognosis. Chest 93:318-324.
7. Chatila TA. 2005. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116:949-959.
8. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. 2003. Conversion of peripheral CD4 + CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875-1886. (Pubitemid 38032120)
9. Chen X, Baumel M, Mannel DN, Howard Z, Oppenheim JJ. 2007. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ regulatory cells. J Immunol 179:154-161. (Pubitemid 46986529)
10. Choileain NN, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. 2006. Enhanced regulatory T cell activity is an element of the response to injury. J Immunol 176:225-236. (Pubitemid 43023267)
11. Codarri L, Vallotton L, Ciuffreda D, Venetz JP, Garcia M, Hadaya K, Buhler L, Rotman S, Pascual M, Pantaleo G. 2007. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients. J Exp Med 204:1533-1541. (Pubitemid 47048021)
12. Cozzo C, Larkin J, Caton AJ. 2003. Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol 171:5678-5682. (Pubitemid 37467181)
13. Cupedo T, Nagasawa M, Weijer K, Blom B, Spits H. 2005. Development and activation of regulatory T cells in the human fetus. Eur J Immunol 35:383-390. (Pubitemid 40331315)
14. Darrasse-Jeze G, Marodon G, Salomon BL, Catala M, Klatzmann D. 2005. Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses. Blood 105:4715-4721. (Pubitemid 40807294)
15. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Puccetti P. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4:1206-1212. (Pubitemid 37547898)
16. Fehervari Z, Sakaguchi S. 2004. Development and function of CD25+CD4+ regulatory T cells.CurrOpin Immunol 16:203-208. (Pubitemid 38332029)
17. Fontenot JD, Gavin MA, Rudensky AY. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330-336. (Pubitemid 36432314)
18. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. 2005, Regulatory T cell lineage specification by the fork-head transcription factor foxp3. Immunity 22:329-341. (Pubitemid 40387475)
19. Gallimore A, Sakaguchi S. 2002. Regulation of tumour immunity by CD25+ T cells. Immunology 107:5-9.
20. Garba ML, Pilcher CD, Bingham AL, Eron J, Frelinger JA. 2002. HIV antigens can induce TGF-b1-producing immunoregulatory CD8+ T cells. J Immunol 168:2247-2254. (Pubitemid 34173033)
21. Gavin MA,Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 103:6659-6664.
22. Haynes LM, Vanderlugt CL, Dal Canto MC, Melvold RW, Miller SD. 2000. CD8( + ) T cells from Theilers virus-resistant BALB/ cByJ mice downregulate pathogenic virus-specific CD4( +) T cells. J Neuro Immunol 106:43-52. (Pubitemid 30256076)
23. Hein F, Massin F, Carvoisy-Popovic A, Barraud D, Levy B, Bollaert PE, Gibot S. 2010. The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock states. Crit Care 14:R19.
24. Heuer JG, Zhang T, Zhao J, Ding C, Cramer M, Justen KL, Vonderfecht SL, Na S. 2005. Adoptive transfer of in vitrostimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol 174:7141-7146. (Pubitemid 40705680)
25. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061. (Pubitemid 36222930)
26. Hotchkiss RS, Karl IE. 2003. The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150. (Pubitemid 36056721)
27. Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH, Cobb JP, Coopersmith C, Karl IE. 2002. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 168:2493-2500. (Pubitemid 34171855)
28. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr., Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG, Karl IE. 2001. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166:6952-6963. (Pubitemid 32467243)
29. Hoyt DB, Ozkan AN, Ninnemann JL, Hansbrough JF, Pinney E, Wormsley S. 1988. Trauma peptide induction of lymphocyte changes predictive of sepsis. J Surg Res 45:342-348.
30. Huang LF, Yao YM, Dong N, Yu Y, He LX, Sheng ZY. 2010. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: A prospective, observational study. Crit Care 14:R3.
31. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S. 1999. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162:5317-5326. (Pubitemid 29307138)
32. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 22:394-400. (Pubitemid 32673646)
33. Kessel A, Bamberger E, Masalha M, Toubi E. 2009. The role of T regulatory cells in human sepsis. J Autoimmun 32:211-215.
34. Khattri R, Cox T, Yasayko SA, Ramsdell F. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337-342. (Pubitemid 36432315)
35. Kingsley CI, Karim M, Bushell AR, Wood KJ. 2002. CD25+CD4+regulatory T cells prevent graft rejection: CTLA-4 and IL-10 dependent immunoregulation of alloresponses. J Immunol 168:1080-1086. (Pubitemid 34094471)
36. Kohm AP, Williams JS, Miller SD. 2004. Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. J Immunol 172:4686-4690. (Pubitemid 38456388)
37. Levings MK, Roncarolo MG. 2005. Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T cells. Curr Top Microbiol Immunol 293:303-326. (Pubitemid 40791235)
38. Lin RY, Astiz ME, Saxon JC, Rackow EC. 1993. Altered leukocyte immunophenotypes in septic shock: Studies of HLA-DR, CD11b, CD14, and IL-2 R epression. Chest 104:847-853. (Pubitemid 23268960)
39. Liu W, Putnam AL, Zhou XY, Szot GL, Lee MR, Zhu S, Gottlieb P, Kapranov P, Gingeras TR, Groth BFdS, Clayberger C, Soper DM, Ziegler SF, Bluestone JA. 2006. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 203:1701-1711. (Pubitemid 44036276)
40. MacConmara MP, Maung AA, Fujimi S, McKenna AM, Delisle A, Lapchak PH, Rogers S, Lederer JA, Mannick JA. 2006. Increased CD4+CD25+ T Regulatory Cell Activity in Trauma Patients Depresses Protective Th1 Immunity. Ann Surg 244: 514-523.
41. Martin GS, Mannino DM, Eaton S, Moss M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554. (Pubitemid 36437931)
42. Mills KHG. 2004. Regulatory T cells: Friend or foe in immunity to infection? Nat Rev Immunol 4:841-855. (Pubitemid 39490760)
43. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A. 2003. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 31:2068-2071. (Pubitemid 36900766)
44. Monneret G, Venet F, Pachot A, Lepape A. 2008. Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol Med 14:64-78. (Pubitemid 351356886)
45. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W. 2004. TGF-b1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172:834-842. (Pubitemid 38113739)
46. Nishijima MK, Takezawa J, Hosotsubo KK, Takahashi H, Shimada Y, Yoshiya I. 1986. Serial changes in cellular immunity of septic patients with multiple organ-system failure. Crit Care Med 14:87-91. (Pubitemid 16155923)
47. Pillai V, Ortega SB, Wang CK, Karandikar NJ. 2007. Transient regulatory T-cells:a state attained by all activated human Tcells. Clin Immunol 123:18-29. (Pubitemid 46401504)
48. Ramsdell F. 2003. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19:165-168. (Pubitemid 37011331)
49. Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G, Ayroldi E, Riccardi C. 2004. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 34:613-622. (Pubitemid 39255908)
50. Saito K, Wagatsuma T, Toyama H, Ejima Y, Hoahi K, Shibusawa M, Kato M, Klrosawa S. 2008. Sepsis is characterized by the increases in percentages of circulating CD4+CD25+ regulatory T cells and plasma level of soluble CD25. Tohoku J Exp Med 216:61-68.
51. Sakaguchi S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458.
52. Sakaguchi S, Sakaguchi N, Asano M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cellsexpressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164.
53. Scumpia PO, Delano MJ, Kelly KM, O Malley KA, McAuliffe PF, Brusko T, Ungaro R, Barker T, Wynn JL, Atkinson MA, Reeves WH, Salzler MJ, Moldawer LL. 2006. Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 177:7943-7949. (Pubitemid 44846310)
54. Scumpia PO, Delano MJ, Kelly-Scumpia KM, Weinstein JS, Wynn JL, Winfield RD, Xia C, Chung CS, Ayala A, Atkinson MA, Reeves WH, Clare-Salzler MJ, Moldawer LL. 2007. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood 110:3673-3681. (Pubitemid 350159636)
55. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, Fazekas de St Groth B. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203:1693-1700. (Pubitemid 44036275)
56. Shevach EM. 2000. Regulatory T cells in autoimmunity. Annu Rev Immunol 18:423-429.
57. Shevach EM. 2002. CD4+CD25+ suppressor T cells:more questions than answers. Nat Rev Immunol 2:389-400. (Pubitemid 37328746)
58. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. 2002. Stimulation ofCD25( + )CD4( + ) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3:135-140.
59. Sprung CL, Sakr Y, Vincent JL, Le Gall JR, Reinhart K, Ranieri VM, Gerlach H, Fielden J, Groba CB, Payen D. 2006. An evaluation of systemic inflammatory response syndrome signs in the sepsis occurrence in acutely ill patients (SOAP) study. Intensive Care Med 32:421-427. (Pubitemid 43289651)
60. Suvas S, Azkur AK, Kim BS, Kumaraquru U, Rouse BT. 2004. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172:4123-4132. (Pubitemid 38375224)
61. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, M. Itoh M, Iwata M, Shimizu J, and Sakaguchi S. 1998. Immunologic selftolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10: 1969-1980. (Pubitemid 28566059)
62. Taylor AL, Llewelyn MJ. 2010. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype. J Immunol 185:6591-6598.
63. Venet F, Chuang CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Bohe J, Lepape A, Ayala A, Monneret G. 2009. Increased circulating regulatory T cells (CD4+CD25+CD127-) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35:678-686.
64. Venet F, Chung CS, Monneret G, Huang X, Horner B, Garber M, Ayala A. 2008. Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 83:523-535. (Pubitemid 351966861)
65. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Monneret G. 2004. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med 32:2329-2331. (Pubitemid 39491817)
66. Wan YY, Flavell RA. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A 102:5126-5131.
67. Wang J, Ioan-Facsinay A, vander Voort EI, Huizinga TW, Toes RE. 2007. Transient expression of FOXP3 in human activated nonregulatory. Eur J Immunol 37:21-23.
68. Weiner HL. 2001. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta -secreting regulatory cells. Microbes Infect 3:947-954. (Pubitemid 32835309)
69. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G. 2003. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 31:2316-2323. (Pubitemid 37100834)
70. Wisnoski N, Chung CS, Chen Y, Huang X, Ayala A. 2007. The contribution of CD4+CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 27:251-257.
71. Wood KJ, Sakaguchi S. 2003. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3:199-210. (Pubitemid 37323205)
72. Xu CT, Li WM, Yao YM. 2008. Regulation mechanism of regulatory T cells in immunoregulatory responses. Int J Pathol Clin Med 28:199-204.
73. Yao YM, Huang LF, Lin HY. 2007. Improvement in understanding of potential mechanism and immunomodulatory strategy for sepsis. Trauma Surg 9:4-7.
74. Yao YM, Sheng ZY, Huang LF. 2009. The effect of a novel cytokine, high mobility group box-1 protein, on the development of traumatic sepsis. Chin J Integr Med 15:13-15.
75. Yende S, Kellum JA. 2009. Understangding genetics of sepsis: will new technology help? Crit Care 13:141-142.
76. Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL. 2004. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16: 249-256. (Pubitemid 38195655)